JP2016535781A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016535781A5 JP2016535781A5 JP2016552446A JP2016552446A JP2016535781A5 JP 2016535781 A5 JP2016535781 A5 JP 2016535781A5 JP 2016552446 A JP2016552446 A JP 2016552446A JP 2016552446 A JP2016552446 A JP 2016552446A JP 2016535781 A5 JP2016535781 A5 JP 2016535781A5
- Authority
- JP
- Japan
- Prior art keywords
- component
- composition
- composition according
- ionic liquid
- skin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000000203 mixture Substances 0.000 claims description 47
- 239000002608 ionic liquid Substances 0.000 claims description 21
- 150000001768 cations Chemical class 0.000 claims description 11
- 125000000129 anionic group Chemical group 0.000 claims description 10
- 125000002091 cationic group Chemical group 0.000 claims description 9
- 239000003814 drug Substances 0.000 claims description 9
- 229940079593 drug Drugs 0.000 claims description 9
- 150000003839 salts Chemical group 0.000 claims description 9
- 208000017520 skin disease Diseases 0.000 claims description 8
- 201000010099 disease Diseases 0.000 claims description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 6
- -1 fatty acid salt Chemical class 0.000 claims description 5
- ZHYZQXUYZJNEHD-VQHVLOKHSA-N geranic acid Chemical compound CC(C)=CCC\C(C)=C\C(O)=O ZHYZQXUYZJNEHD-VQHVLOKHSA-N 0.000 claims description 5
- 229930008392 geranic acid Natural products 0.000 claims description 5
- 230000000813 microbial effect Effects 0.000 claims description 5
- ZHYZQXUYZJNEHD-UHFFFAOYSA-N trans-geranic acid Natural products CC(C)=CCCC(C)=CC(O)=O ZHYZQXUYZJNEHD-UHFFFAOYSA-N 0.000 claims description 5
- GLZPCOQZEFWAFX-UHFFFAOYSA-N Geraniol Chemical compound CC(C)=CCCC(C)=CCO GLZPCOQZEFWAFX-UHFFFAOYSA-N 0.000 claims description 4
- 239000002253 acid Substances 0.000 claims description 4
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 claims description 4
- 229960001231 choline Drugs 0.000 claims description 4
- BCKXLBQYZLBQEK-KVVVOXFISA-M Sodium oleate Chemical compound [Na+].CCCCCCCC\C=C/CCCCCCCC([O-])=O BCKXLBQYZLBQEK-KVVVOXFISA-M 0.000 claims description 3
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 3
- 229930195729 fatty acid Natural products 0.000 claims description 3
- 239000000194 fatty acid Substances 0.000 claims description 3
- 231100000344 non-irritating Toxicity 0.000 claims description 3
- UDWXLZLRRVQONG-UHFFFAOYSA-M sodium hexanoate Chemical compound [Na+].CCCCCC([O-])=O UDWXLZLRRVQONG-UHFFFAOYSA-M 0.000 claims description 3
- AHXNYDBSLAVPLY-UHFFFAOYSA-M 1,1,1-trifluoro-N-(trifluoromethylsulfonyl)methanesulfonimidate Chemical compound [O-]S(=O)(=NS(=O)(=O)C(F)(F)F)C(F)(F)F AHXNYDBSLAVPLY-UHFFFAOYSA-M 0.000 claims description 2
- GNPSDJOWGWWXSS-UHFFFAOYSA-M 1-benzylpyridin-1-ium;chloride Chemical compound [Cl-].C=1C=CC=C[N+]=1CC1=CC=CC=C1 GNPSDJOWGWWXSS-UHFFFAOYSA-M 0.000 claims description 2
- LZZAIUPBRFPFDS-UHFFFAOYSA-N 3-(dimethylazaniumyl)pentadecane-3-sulfonate Chemical compound CCCCCCCCCCCCC(CC)(N(C)C)S(O)(=O)=O LZZAIUPBRFPFDS-UHFFFAOYSA-N 0.000 claims description 2
- 208000002874 Acne Vulgaris Diseases 0.000 claims description 2
- 206010012438 Dermatitis atopic Diseases 0.000 claims description 2
- 208000010201 Exanthema Diseases 0.000 claims description 2
- 206010016936 Folliculitis Diseases 0.000 claims description 2
- 206010017533 Fungal infection Diseases 0.000 claims description 2
- 239000005792 Geraniol Substances 0.000 claims description 2
- GLZPCOQZEFWAFX-YFHOEESVSA-N Geraniol Natural products CC(C)=CCC\C(C)=C/CO GLZPCOQZEFWAFX-YFHOEESVSA-N 0.000 claims description 2
- 208000031888 Mycoses Diseases 0.000 claims description 2
- 206010052428 Wound Diseases 0.000 claims description 2
- 208000027418 Wounds and injury Diseases 0.000 claims description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 2
- 206010000496 acne Diseases 0.000 claims description 2
- 201000008937 atopic dermatitis Diseases 0.000 claims description 2
- 229960003872 benzethonium Drugs 0.000 claims description 2
- SIYLLGKDQZGJHK-UHFFFAOYSA-N dimethyl-(phenylmethyl)-[2-[2-[4-(2,4,4-trimethylpentan-2-yl)phenoxy]ethoxy]ethyl]ammonium Chemical compound C1=CC(C(C)(C)CC(C)(C)C)=CC=C1OCCOCC[N+](C)(C)CC1=CC=CC=C1 SIYLLGKDQZGJHK-UHFFFAOYSA-N 0.000 claims description 2
- 239000000839 emulsion Substances 0.000 claims description 2
- 201000005884 exanthem Diseases 0.000 claims description 2
- 229940113087 geraniol Drugs 0.000 claims description 2
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical class CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 claims description 2
- 208000015181 infectious disease Diseases 0.000 claims description 2
- 229940071204 lauryl sarcosinate Drugs 0.000 claims description 2
- 239000007788 liquid Substances 0.000 claims description 2
- 239000004530 micro-emulsion Substances 0.000 claims description 2
- 150000002888 oleic acid derivatives Chemical class 0.000 claims description 2
- XYFCBTPGUUZFHI-UHFFFAOYSA-O phosphonium Chemical compound [PH4+] XYFCBTPGUUZFHI-UHFFFAOYSA-O 0.000 claims description 2
- 206010037844 rash Diseases 0.000 claims description 2
- 206010040872 skin infection Diseases 0.000 claims description 2
- 125000005497 tetraalkylphosphonium group Chemical group 0.000 claims description 2
- 239000011701 zinc Substances 0.000 claims description 2
- 229910052725 zinc Inorganic materials 0.000 claims description 2
- 150000001450 anions Chemical class 0.000 claims 9
- 239000003242 anti bacterial agent Substances 0.000 claims 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims 1
- 229940088710 antibiotic agent Drugs 0.000 claims 1
- 229940121375 antifungal agent Drugs 0.000 claims 1
- 239000003429 antifungal agent Substances 0.000 claims 1
- 229960005475 antiinfective agent Drugs 0.000 claims 1
- 239000004599 antimicrobial Substances 0.000 claims 1
- 239000002246 antineoplastic agent Substances 0.000 claims 1
- 239000003443 antiviral agent Substances 0.000 claims 1
- 239000007844 bleaching agent Substances 0.000 claims 1
- 102000039446 nucleic acids Human genes 0.000 claims 1
- 108020004707 nucleic acids Proteins 0.000 claims 1
- 150000007523 nucleic acids Chemical class 0.000 claims 1
- 102000004169 proteins and genes Human genes 0.000 claims 1
- 108090000623 proteins and genes Proteins 0.000 claims 1
- 229910052708 sodium Inorganic materials 0.000 claims 1
- 239000011734 sodium Substances 0.000 claims 1
- 230000000699 topical effect Effects 0.000 claims 1
- 238000000034 method Methods 0.000 description 11
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 208000037765 diseases and disorders Diseases 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000013271 transdermal drug delivery Methods 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361899294P | 2013-11-03 | 2013-11-03 | |
| US61/899,294 | 2013-11-03 | ||
| PCT/US2014/063745 WO2015066647A2 (en) | 2013-11-03 | 2014-11-03 | Ionic liquids for transdermal drug delivery |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019030302A Division JP6674058B2 (ja) | 2013-11-03 | 2019-02-22 | 経皮薬物送達のためのイオン性液体 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2016535781A JP2016535781A (ja) | 2016-11-17 |
| JP2016535781A5 true JP2016535781A5 (enExample) | 2017-12-07 |
Family
ID=53005413
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016552446A Withdrawn JP2016535781A (ja) | 2013-11-03 | 2014-11-03 | 経皮薬物送達のためのイオン性液体 |
| JP2019030302A Active JP6674058B2 (ja) | 2013-11-03 | 2019-02-22 | 経皮薬物送達のためのイオン性液体 |
| JP2020037741A Withdrawn JP2020097633A (ja) | 2013-11-03 | 2020-03-05 | 経皮薬物送達のためのイオン性液体 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019030302A Active JP6674058B2 (ja) | 2013-11-03 | 2019-02-22 | 経皮薬物送達のためのイオン性液体 |
| JP2020037741A Withdrawn JP2020097633A (ja) | 2013-11-03 | 2020-03-05 | 経皮薬物送達のためのイオン性液体 |
Country Status (7)
| Country | Link |
|---|---|
| US (3) | US10449254B2 (enExample) |
| EP (1) | EP3062819B1 (enExample) |
| JP (3) | JP2016535781A (enExample) |
| KR (1) | KR102286115B1 (enExample) |
| CA (2) | CA2929630C (enExample) |
| ES (1) | ES2908345T3 (enExample) |
| WO (1) | WO2015066647A2 (enExample) |
Families Citing this family (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BRPI0811530B1 (pt) | 2007-05-14 | 2019-01-02 | Research Foundation Of State Univ Of New York | composição compreendendo indutor(es) de resposta fisiológica à dispersão ácido decanóico, superfície, solução, método ex vivo de tratamento ou inibição da formação de um biofilme sobre uma superfície |
| EP3395368A1 (en) * | 2014-10-30 | 2018-10-31 | Asahi Kasei Kabushiki Kaisha | Transdermal absorption enhancer and transdermal absorption enhancement aid |
| CA2931913C (en) | 2015-06-12 | 2024-03-19 | Kemira Oyj | Bitumen separation using ionic liquids comprising unsubstituted or substituted primary, secondary or tertiary amines, pyridines, amidines, guanidines and fatty acids and/or resin acids |
| US10912834B2 (en) | 2016-08-29 | 2021-02-09 | The Regents Of The University Of California | Topical formulations based on ionic species for skin treatment |
| US11274137B1 (en) * | 2016-10-04 | 2022-03-15 | United States Of America As Represented By The Secretary Of The Air Force | Ultra-stable protein ionic liquids |
| US10828265B2 (en) | 2016-12-09 | 2020-11-10 | The Regents Of The University Of California | Formulations of propranolol and analogs as an amorphous melt or ionic liquid for transdermal drug delivery |
| US11213497B2 (en) | 2017-06-01 | 2022-01-04 | Arizona Board Of Regents On Behalf Of Northern Arizona University | Antibiofilm formulations |
| WO2019099837A1 (en) * | 2017-11-17 | 2019-05-23 | President And Fellows Of Harvard College | Ionic liquids for internal delivery |
| JP2019131480A (ja) * | 2018-01-29 | 2019-08-08 | 旭化成株式会社 | 経皮吸収促進剤及び経皮製剤 |
| AU2019239949B2 (en) * | 2018-03-19 | 2025-06-12 | Cage Bio Inc. | Ionic liquid compositions for treatment of rosacea |
| US11541105B2 (en) | 2018-06-01 | 2023-01-03 | The Research Foundation For The State University Of New York | Compositions and methods for disrupting biofilm formation and maintenance |
| KR101959524B1 (ko) * | 2018-09-19 | 2019-03-18 | 주식회사 우신라보타치 | 리도카인을 포함한 이온토포레시스용 점착성 카타플라스마 시스템 |
| WO2020180534A1 (en) | 2019-03-01 | 2020-09-10 | President And Fellows Of Harvard College | Methods and compositions for protein delivery |
| KR20220004066A (ko) * | 2019-04-03 | 2022-01-11 | 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 | 약물 전달용 이온성 액체 |
| ES2912262T3 (es) * | 2019-05-29 | 2022-05-25 | Hopitaux Paris Assist Publique | Sistema eutéctico de las catequinas del té verde |
| EP4054527A4 (en) * | 2019-11-08 | 2023-12-06 | Cage Bio Inc. | TOPICAL ADMINISTRATION OF TOFACITINIB USING IONIC LIQUID |
| CN114980864A (zh) | 2019-11-22 | 2022-08-30 | 哈佛大学校长及研究员协会 | 用于药物递送的离子液体 |
| WO2021119198A1 (en) * | 2019-12-09 | 2021-06-17 | Cage Bio, Inc. | Topical delivery of rna interference agents using ionic liquid |
| US11684594B2 (en) | 2020-05-12 | 2023-06-27 | President And Fellows Of Harvard College | Antifungal prophylaxis for cornea |
| EP4171761A4 (en) * | 2020-06-26 | 2024-07-24 | Cage Bio Inc. | DISINFECTANT COMPOSITIONS CONTAINING IONIC LIQUID |
| CA3191727A1 (en) | 2020-08-14 | 2022-02-17 | Mayo Foundation For Medical Education And Research | Methods and materials for tissue ablation |
| EP4225324A4 (en) * | 2020-10-05 | 2024-11-13 | Cage Bio Inc. | IONIC LIQUID COMPOSITIONS FOR SKIN DISEASES AND CONDITIONS |
| KR102577838B1 (ko) | 2020-10-29 | 2023-09-12 | 히사미쓰 세이야꾸 가부시키가이샤 | 로피니롤 함유 첩부제 및 로피니롤의 피부 투과성 향상 방법 |
| US20230415070A1 (en) * | 2020-11-13 | 2023-12-28 | Universidade Do Minho | Eutectic compositions, methods and uses thereof |
| CN113171339A (zh) * | 2021-03-10 | 2021-07-27 | 华东理工大学 | 格列齐特离子液体及其制备方法和应用 |
| WO2022256291A1 (en) | 2021-06-01 | 2022-12-08 | President And Fellows Of Harvard College | Hydrogel devices for drug delivery to the ear |
| WO2022271537A1 (en) | 2021-06-25 | 2022-12-29 | President And Fellows Of Harvard College | Compositions and methods relating to injectable microemulsions |
| US12005134B2 (en) | 2021-06-30 | 2024-06-11 | Abe Pharmaceutical | Composition for stimulating facial hair growth and methods of manufacturing a composition for stimulating facial hair growth |
| JP2024538700A (ja) | 2021-10-08 | 2024-10-23 | プレジデント・アンド・フェロウズ・オブ・ハーバード・カレッジ | 薬物送達のためのイオン液体 |
| CA3237751A1 (en) | 2021-11-10 | 2023-05-19 | Tyler Brown | Ionic liquid compositions |
| CN116474153B (zh) * | 2022-01-17 | 2024-09-27 | 四川大学 | 一种基于竹纤维-低共熔溶剂-明胶的皮肤溃疡护理贴膜 |
| WO2023205615A1 (en) | 2022-04-18 | 2023-10-26 | ISHA Therapeutics LLC | Orally dissolving antimicrobial film compositions & methods of their use |
| CN115671285B (zh) * | 2022-08-24 | 2024-01-05 | 上海市皮肤病医院 | 一种抗真菌溶液及其制备方法和应用 |
| WO2025147130A1 (ko) * | 2024-01-03 | 2025-07-10 | 주식회사 바이온리퀴드 | 이온성 액체 또는 공융 용매를 이용한 신규 약물제형 |
| WO2026030695A1 (en) * | 2024-08-02 | 2026-02-05 | President And Fellows Of Harvard College | Compositions and methods relating to carboxylic acid ionic liquids |
| WO2026041873A1 (en) * | 2024-08-21 | 2026-02-26 | The University Of Reading | Compositions for systemic administration |
Family Cites Families (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3342840A (en) * | 1964-03-23 | 1967-09-19 | Shell Oil Co | Cationic ester production |
| US4042327A (en) | 1976-01-15 | 1977-08-16 | Waters Associates, Inc. | Ion-pairing chromatography |
| US4897355A (en) | 1985-01-07 | 1990-01-30 | Syntex (U.S.A.) Inc. | N[ω,(ω-1)-dialkyloxy]- and N-[ω,(ω-1)-dialkenyloxy]-alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor |
| JPS62209523A (ja) | 1986-03-11 | 1987-09-14 | Fuji Photo Film Co Ltd | 感光材料 |
| US4892737A (en) * | 1988-09-22 | 1990-01-09 | University Of Florida | Composition and method for enhancing permeability of topical drugs |
| HU203372B (en) | 1989-02-24 | 1991-07-29 | Richter Gedeon Vegyeszet | Process for producing hyaluronic associates and pharmaceutical compositions and cosmetics comprising such active ingredient |
| US5714331A (en) | 1991-05-24 | 1998-02-03 | Buchardt, Deceased; Ole | Peptide nucleic acids having enhanced binding affinity, sequence specificity and solubility |
| US5539082A (en) | 1993-04-26 | 1996-07-23 | Nielsen; Peter E. | Peptide nucleic acids |
| US5356802A (en) | 1992-04-03 | 1994-10-18 | The Johns Hopkins University | Functional domains in flavobacterium okeanokoites (FokI) restriction endonuclease |
| US5487994A (en) | 1992-04-03 | 1996-01-30 | The Johns Hopkins University | Insertion and deletion mutants of FokI restriction endonuclease |
| US5527675A (en) | 1993-08-20 | 1996-06-18 | Millipore Corporation | Method for degradation and sequencing of polymers which sequentially eliminate terminal residues |
| DE4331012A1 (de) | 1993-09-13 | 1995-03-16 | Bayer Ag | Nukleinsäuren-bindende Oligomere mit N-Verzweigung für Therapie und Diagnostik |
| US5674908A (en) | 1993-12-20 | 1997-10-07 | Life Technologies, Inc. | Highly packed polycationic ammonium, sulfonium and phosphonium lipids |
| ATE281075T1 (de) * | 1994-03-28 | 2004-11-15 | Univ Columbia | Zusammensetzung zum inaktivieren von reizstoffen in flüssigkeiten |
| KR19990022598A (ko) | 1995-06-07 | 1999-03-25 | 다니엘 엘. 캐시앙, 헨리 엘. 노르호프 | 미셀 보호 분석법 |
| US5786571A (en) | 1997-05-09 | 1998-07-28 | Lexmark International, Inc. | Wrapped temperature sensing assembly |
| ES2298438T3 (es) | 2001-12-21 | 2008-05-16 | Rhodia Inc. | Composiciones estables combinadas de tensioactivos cationicos y anionicos. |
| US7102000B2 (en) * | 2002-03-08 | 2006-09-05 | Incyte San Diego Inc. | Heterocyclic amide derivatives for the treatment of diabetes and other diseases |
| US6858217B2 (en) * | 2002-03-22 | 2005-02-22 | Unilever Home & Personal Care Usa Division Of Conopco, Inc. | Stabilization of terpenoids in cosmetic compositions |
| ATE413166T1 (de) | 2004-11-22 | 2008-11-15 | Hisamitsu Pharmaceutical Co | Transdermales pflaster enthaltend einen schmelzpunktsenkenden hilfsstoff |
| US9139850B2 (en) | 2005-05-19 | 2015-09-22 | L'oreal | Vectorization of dsRNA by cationic particles and topical use |
| WO2007124397A2 (en) | 2006-04-21 | 2007-11-01 | Trustees Of Boston University | Ionic viscoelastics and viscoelastic salts |
| WO2008031105A1 (en) | 2006-09-08 | 2008-03-13 | Delaval Holdings Ab | Polymeric guanidine salt-based germicides |
| JP5117732B2 (ja) | 2007-01-29 | 2013-01-16 | 株式会社 メドレックス | 外用剤用の低刺激性溶解助剤 |
| JP4952272B2 (ja) | 2007-01-29 | 2012-06-13 | 株式会社ツムラ | （ｚ）−リグスチリドの製造方法 |
| US8247198B2 (en) | 2007-09-21 | 2012-08-21 | Friedrich Srienc | Enzymatic processing in deep eutectic solvents |
| CN103239721B (zh) * | 2007-11-22 | 2016-03-16 | 美德阿利克斯株式会社 | 包括基于脂肪酸的离子型液体作为活性成分的外用制剂组合物 |
| US8022014B2 (en) | 2008-03-26 | 2011-09-20 | Shrieve Chemical Products, Inc. | Deep eutectic solvents and applications |
| JP5681883B2 (ja) | 2009-03-27 | 2015-03-11 | 株式会社 メドレックス | 核酸を有効成分とする外用剤組成物 |
| WO2011056545A2 (en) | 2009-10-26 | 2011-05-12 | Trustees Of Boston University | Antimicrobial ionic liquids |
| WO2011057209A1 (en) | 2009-11-06 | 2011-05-12 | Qlt, Inc. | Acidic ophthalmic formulations |
| PT2816112T (pt) | 2009-12-10 | 2018-11-20 | Univ Iowa State Res Found Inc | Modificação do adn modificada pelo efector tal |
| JP6148676B2 (ja) | 2011-11-04 | 2017-06-14 | リポテック， エセ．ア． | 活性化受容体を阻害するペプチド、および化粧品組成物または薬学的組成物におけるそれらの使用 |
| EP2597099B1 (en) | 2011-11-23 | 2018-08-15 | King Saud University | Deep eutectic solvent and method for its preparation |
| EP2740484A1 (en) | 2012-12-05 | 2014-06-11 | Lipotec, S.A. | Compounds useful in the treatment and/or care of the skin, hair and/or muccous membranes and their cosmetic or pharmaceutical compositions |
| FR3002452B1 (fr) | 2013-02-28 | 2016-02-12 | Dermaconcept Jmc | Composition dermatologique antimicrobienne topique |
| CN105434337B (zh) | 2015-04-03 | 2019-08-16 | 武汉科福新药有限责任公司 | 盐酸普萘洛尔亚微乳凝胶及其制备方法和用途 |
-
2014
- 2014-11-03 EP EP14859243.9A patent/EP3062819B1/en active Active
- 2014-11-03 US US15/034,138 patent/US10449254B2/en active Active
- 2014-11-03 CA CA2929630A patent/CA2929630C/en active Active
- 2014-11-03 JP JP2016552446A patent/JP2016535781A/ja not_active Withdrawn
- 2014-11-03 KR KR1020167014980A patent/KR102286115B1/ko active Active
- 2014-11-03 WO PCT/US2014/063745 patent/WO2015066647A2/en not_active Ceased
- 2014-11-03 CA CA3100536A patent/CA3100536A1/en not_active Abandoned
- 2014-11-03 ES ES14859243T patent/ES2908345T3/es active Active
-
2019
- 2019-02-22 JP JP2019030302A patent/JP6674058B2/ja active Active
- 2019-06-21 US US16/448,335 patent/US11786597B2/en active Active
-
2020
- 2020-03-05 JP JP2020037741A patent/JP2020097633A/ja not_active Withdrawn
-
2023
- 2023-09-22 US US18/472,966 patent/US20240156964A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019073561A5 (enExample) | ||
| US12134628B2 (en) | Antimicrobial organosilanes | |
| PH12017502092A1 (en) | Topical pharmaceutical compositions | |
| JP6267218B2 (ja) | 揮発性、疎水性溶媒を用いた生物学的に活性な薬剤の送達 | |
| NZ711225A (en) | A pharmaceutical formulation comprising omecamtiv mecarbil, processess and uses | |
| AU2019219767A1 (en) | Treatments for resistant acne | |
| WO2018191450A3 (en) | GENE THERAPY FOR A DEFICIENCY IN AADC | |
| MX2018004376A (es) | Formulaciones inyectables de neuroesteroides que contienen nanoparticulas. | |
| WO2015066647A3 (en) | Ionic liquids for transdermal drug delivery | |
| MY199903A (en) | Combination therapy with controlled-release cnp agonists | |
| MX2019013701A (es) | Metodos para mejorar suministro de farmacos y efectividad de agentes terapeuticos. | |
| JP2018512454A5 (enExample) | ||
| KR20120022930A (ko) | 은 설파디아진 및 키토산을 사용하여 제조한 약용 크림 및 이의 제조 방법 | |
| EP4552650A3 (en) | Methods and compositions for treatment of skin | |
| JP2016540785A5 (enExample) | ||
| RU2014150505A (ru) | Способ идентификации лигандов рецептора ahr, которые обладают терапевтической себосупрессивной активностью, и указанные лиганды | |
| JP2018509388A5 (enExample) | ||
| MX2016009063A (es) | Preparacion farmaceutica que contiene compuesto de acido piridilaminoacetico. | |
| MX395613B (es) | COMPOSICIONES DE ZINC-y-PGA Y MÉTODOS PARA TRATAR EL CANCER. | |
| MX2023009600A (es) | Análogos de la oxa-ibogaína para el tratamiento de trastornos por consumo de sustancias. | |
| AR109012A1 (es) | Sistema de administración transdérmica que contiene galantamina o sales de esta | |
| NZ703176A (en) | Stable pexiganan formulation | |
| EP4234021A3 (en) | Pharmaceutical composition comprising an adenosine derivative for use in the prevention or treatment of diabetic nephropathy | |
| JP2020519656A5 (enExample) | ||
| CN103127544A (zh) | 含银壳聚糖敷料及其制备方法和用途 |